UNI-PHARMA Pharmaceutical Laboratories S.A.

Honoring Ceremony in Memory of Kleon Tsetis, Founder of OFET, in Arta -& the KLEON TSETIS NPCC that Continues to Bring His Vision to Life   An honoring ceremony was held on Wednesday, March 12, 2025, in Arta, the birthplace of visionary scientist and pioneering entrepreneur Kleon Tsetis, founder of UNI-PHARMA Pharmaceutical Laboratories S.A. & InterMed Pharmaceutical Laboratories S.A. , marking fifteen years since his passing. The event took place under the auspices of the Municipality of Arta. The Mayor of Arta, Mr. Christoforos Siafakas, began his speech by highlighting the remarkable contributions of the late Kleon Tsetis in the fields of health, industry, and society—a journey that left a distinct and lasting impact. He also emphasized how the Tsetis family continues his legacy, remaining faithful to his life philosophy. With honor and respect for the journey and contributions of Kleon Tsetis, speeches were delivered by the Metropolitan of Arta, Kallinikos; the Minister of Health, Mr. Adonis Georgiadis; Members of Parliament, Ms. Olga Gerovasili and Mr. Georgios Stylios; the President of the Πανελλήνια Ένωση Φαρμακοβιομηχανίας (ΠΕΦ) - PEF, Mr. THEODOROS TRYFON; the President of the Panhellenic Pharmaceutical Association (ΠΦΣ) , Mr. Apostolos Valtas ; and the author and native of Arta, Ms. Penelope Kourtzi Tsakalos. Ms. Julia Tseti, President and CEO of OFET, MSc Pharmacist, and Honorary Doctor of Pharmacy at the National and Kapodistrian University of Athens and the University of Patras, delivered an emotional speech about her father's notable contributions to science, industry, and society, as well as the Non-Profit Civil Company (NPCC) KLEON TSETIS, established in his memory. Among other things, she mentioned: "It is a day of celebration and honor for my late father, Kleon, whom most of you knew personally—a restless and creative spirit who passed away 15 years ago. He was a man deeply passionate about research, industrial production, pharmaceuticals, and health. In his memory, together with my sister, Irene, we founded the Non-Profit Civil Company KLEON TSETIS, which supports research in medical sciences and culture. It is inspired by our father's vision and the unwavering values that continue to guide the industries he established, UNI-PHARMA and InterMed Pharmaceutical Laboratories. The purpose of the NPCC KLEON TSETIS is to promote and support research and innovation, as well as to advance science and education for the new generation, with the vision of improving health and enhancing the quality of life for people and patients”. #ΑΜΚΕ_ΚΛΕΩΝ_ΤΣΕΤΗΣ #KLEON_TSETIS_NPCC

We are excited to announce our participation in IDS International Dental Show, one of the world’s leading trade fair for the dental industry, taking place in Cologne from March 25 to March 29, 2025. The International Dental Show (IDS) is held every two years and brings together top companies, innovative technologies, and professionals from across the globe. It serves as a premier platform for networking, discovering the latest advancements, and establishing new business collaborations. InterMed Pharmaceutical Laboratories S.A.  will be exhibiting at booth B100-C109/Hall 5.2, where we will showcase our latest innovations in dental products. ✅We look forward to meeting industry professionals, discussing new opportunities, and demonstrating how our solutions can support the evolving needs of the dental sector. ✅We invite you to visit our booth, explore our product range, and connect with us! 📍 Location: Koelnmesse GmbH, Cologne, Germany 📅 Dates: March 25-29, 2025

Some Thoughts on Leadership & Positions of Responsibility- article authored by our President Julia Tseti, published in mononews.gr as part of the special feature on Women in Leadership. "The underrepresentation of women in positions of responsibility, management, and leadership clearly highlights how deeply prejudices still govern us and how far we are from overcoming major and deeply ingrained social stereotypes. While empowering women, providing mentoring, and establishing new leadership models are essential, they are not enough. We urgently need targeted policies and reforms that foster a more inclusive and equitable environment. These initiatives must tangibly and measurably support women's roles in modern entrepreneurship, the economy, senior leadership and management positions, encourage their participation in technology and digital transformation, and recognize their vital contribution to the health sciences. We often talk about women's entrepreneurship and the significant challenges they face. But why don’t we talk about men's entrepreneurship? How fair and inclusive is it to create these distinct lines of reference? The obstacles women face are not only institutional, cultural, financial, economic, or political—they are fundamentally structural. As such, they must be addressed and resolved so that, in the coming decades, the celebration of International Women's Day will no longer be marked by inequality but by true progress and inclusivity". #inclusivity #mononews #WomensDay #WomenInLeadership https://lnkd.in/duV3isF2

Triple Gold Distinction for UNI-PHARMA at the Green Brand Awards UNI-PHARMA Pharmaceutical Laboratories S.A. was honored with three gold distinctions at the Green Brand Awards ceremony, organized by BOUSSIAS Group on Tuesday, March 11, 2025. These awards affirm our long-standing commitment to environmental protection, sustainable development, and eco-friendly practices through innovative and responsible approaches. The distinctions were awarded in three key categories: ✅ Green Building UNI-PHARMA received this award for its state-of-the-art bioclimatic factory, which reflects its dedication to sustainable infrastructure and environmental responsibility. ✅ Green Corporate Training The company was recognized for its educational initiatives in the field of sustainability, emphasizing efforts to integrate green practices and promote environmental awareness within its corporate culture. ✅ Low Energy Equipment UNI-PHARMA was honored for its ongoing investment in low-energy consumption equipment, contributing to the reduction of its environmental footprint. #GreenBrandAwards #UNI_PHARMA

Always by the Side of Children and Supporting the Invaluable Work of ΕΞΕΛΙΞΗ ΖΩΗΣ (LIFE EVOLUTION) We proudly endorse and support the invaluable work of the ΕΞΕΛΙΞΗ ΖΩΗΣ (LIFE EVOLUTION) Non-Profit Organization, sharing a common vision: to build a society that safeguards the rights of all children, ensuring every child has an equal opportunity to grow, thrive, and become an active, autonomous citizen—free from injustice. Exelixi Zois is dedicated to empowering young people living in institutional care, offering opportunities in education, sports, artistic expression, and social development. By standing alongside and supporting children growing up in challenging circumstances, we offer meaningful assistance that empowers them to overcome obstacles and build a future filled with happiness, opportunity, and growth—a future every child deserves. #ExelixiZois #LifeEvolution #EmpoweringYouth #EveryChildMatters #InterMed #UNI_PHARNA

With International Women’s Day around the corner, we are proud to share that our President, Julia Tseti, was among the first CEOs in Greece to sign the Women’s Empowerment Principles (WEPs) as early as 2022. This commitment reflects our group’s unwavering dedication to social responsibility, gender equality, and inclusive leadership. The WEPs, established by UN Women and the UN Global Compact, provide a vital framework for businesses to advance gender equality in the workplace, marketplace, and community. At UNI-PHARMA Pharmaceutical Laboratories S.A. and InterMed Pharmaceutical Laboratories S.A. , we are proud to uphold these principles and continue fostering an inclusive, diverse, and equitable work environment.   #WEPs #InternationalWomensDay #GenderEquality 

Once again, OFET supported the initiatives of the Arab - Hellenic Chamber of Commerce and Development, participating in the 5th Business Forum in the Arab World on February 25 at the Caravel hotel, which was followed by the annual pita-cutting event. The Tsetis Group of Pharmaceutical Companies has long fostered strong collaborations with Arab markets, exporting high-quality pharmaceutical products. As highlighted by George Spigos, International Sales Manager of the Group, these strategic partnerships continue to drive growth and innovation. A noteworthy milestone in this journey was the first Arab-Hellenic Health Conference, successfully organized in May 2024 by the Arab-Hellenic Chamber, with our President, Julia Tseti, as the visionary leader and driving force behind the initiative. Our commitment to fostering international business synergies remains steadfast, paving the way for new opportunities in the pharmaceutical sector. #ArabHellenicChamber #UNI_PHARMA #InterMed

The latest issue of K magazine by Kathimerini was dedicated to women, highlighting key discussions on gender equality and inclusion. In her article, featured in this special issue, our President, Julia Tseti emphasizes the fundamental importance of equity in the workplace—not only as a matter of justice but also as a critical driver of sustainable business growth and social cohesion. As Julia Tsetis underlines: “Inclusion, acceptance of diversity, and gender equality in the workplace is not only a matter of justice but also a timeless challenge for the economy and society. Human capital is the true intangible wealth of every business, and equality is a fundamental prerequisite for prosperity, sustainable development, and business progress. It is also essential for fostering a mutually trusting and cohesive relationship with society. The role of businesses in this regard is critical. The latest survey by SEV (Hellenic Federation of Enterprises), titled "Operation Equality", revealed that the average gross full-time salary for women is 13% lower than that of men, while women remain underrepresented in leadership positions. It is disheartening that 53% of businesses report zero or very limited female participation on their Boards of Directors, while 1 in 10 businesses has no women in a managerial or departmental leadership role. The issue of workplace equality remains an ongoing challenge—one that will define our responsible, committed, and proactive stance toward employees. The country’s business and institutional stakeholders have a moral obligation to remain vigilant and continuously reassess the seamless functioning of each corporate work environment, ensuring the full and comprehensive inclusion of women in business activities. This is precisely where SEV's critical role as a leading employer organization lies: to monitor developments regarding the potential violation—whether in terms of wages, meritocracy, technology, or leadership—of women's rights in the workplace, with consistency and continuity over time”. #WomensDay #GenderEquity #EquityAtWork #Kmagazine

U.S. Withdrawal from the World Health Organization and its broader implications Our President's article in Kathimerini highlights the profound implications of the U.S. decision on global health equity and ethical responsibility. As Julia Tseti states in her article: One of the largest and most powerful countries in the world is withdrawing from an organization it once spearheaded—one whose very foundation bears its imprint. Global superpowers pave the way, while smaller, less influential countries follow suit. But in this case, how can we meaningfully discuss reducing inequalities and fostering inclusion while still addressing matters of global public health? If the COVID-19 pandemic has underscored anything with unmistakable clarity, it is that health crises will persist—indeed, they are only just beginning. The climate crisis, looming large on the horizon, is merely the tip of the iceberg for what is yet to come… Beyond public health emergencies, the global health landscape faces pressing concerns: non-communicable diseases (NCDs), rare disorders, relentless scientific research for groundbreaking therapies, and the continuous development of vaccines—efforts spearheaded by the scientific community and leading research institutions worldwide. Therefore, the U.S. decision to withdraw from the World Health Organization boycotts and hinders precisely these critical efforts, leading not only patients and vulnerable communities but, above all, science itself down dangerous paths. *The article was published in Kathimerini on Saturday February 22, 2025 https://lnkd.in/d6JCbM4c #USA #WHO #Kathimerini

So proud to be part of the global Top Employer community! Certified as Top Employers for the third consecutive year, the teams of InterMed Pharmaceutical Laboratories S.A. and UNI-PHARMA Pharmaceutical Laboratories S.A. , along with our President, Julia Tseti, attended the Top Employer Certification Celebration 2025 in São Paulo—an unforgettable event where excellence and teamwork came together to celebrate the achievements of awarded companies within the global Top Employers Institute community! The President and CEO of the Tsetis Pharmaceutical Companies Group received the award, a testament to our group’s unwavering commitment to excellence, innovation, and employee well-being, reinforcing our dedication to fostering a thriving workplace culture and setting new industry standards. Our People, Our Strength! #InterMed #UNI_PHARMA #TopEmployer #TopEmployer2025